decisionhealth Newsletters, Coder Pink Sheets - 2013 Issue 6 (June)
Follow these drug-billing tips to lower your J-code denial rate, reduce audits
Subscribe or sign in to view the full article.
Article Overview
This article covers common drug-billing issues that can affect claim accuracy, denial risk, and audit exposure in Medicare contexts. It is aimed at coders, billing staff, and clinical practice administrators who work with injectable and infused drugs and need a high-level understanding of documentation, billing setup, place of service, and modifier use.
Why This Topic Matters
Drug claims can be scrutinized closely, and small billing mistakes may trigger denials or audits. The article helps readers understand the major categories of Medicare guidance that influence drug billing workflow and claim preparation.
What You Will Learn
- How drug billing practices can affect claim denials and audit risk
- What kinds of documentation are discussed for drug wastage claims
- How place of service can affect who is reimbursed for drugs
- How dosage/unit reporting is addressed for selected drugs
- Which drug-related modifiers are highlighted in the article
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Revenue cycle teams
- Dialysis and infusion clinic personnel
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com